Metastatic Prostate Cancer: Current Treatment Advances
Event Date
Tuesday, October 06, 2026
1:30 PM - 2:30 PM ET
Presented in Collaboration with:
- Advanced Practitioner Society for Hematology and Oncology (APSHO)
- American Cancer Society Cancer Action Network (ACS CAN)
- American Psychosocial Oncology Society
- American Society of Clinical Oncology
- Association for Molecular Pathology
- Association of Clinicians for the Underserved
- Association of Oncology Social Work
- Black Womens Health Imperative
- Cancer Justice
- Cancer Nation
- Intercultural Cancer Council
- Joe's House
- Multinational Association of Supportive Care in Cancer
- National Alliance of State Prostate Cancer Coalitions
- National Association of Social Workers
- National Comprehensive Cancer Network (NCCN) NCCN Guidelines for Patients
- NeedyMeds
- Prevent Cancer Foundation
- Prostate Cancer Foundation
- Redes en Acción The National Latino Cancer Research Network
- Research Advocacy Network
- Scott Hamilton CARES Foundation
- Triage Cancer
- Vital Options International
- ZERO Prostate Cancer
- The LGBT Cancer Project
This activity is supported by Bristol Myers Squibb. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.
Topics Covered
- Overview of the Treatment of Metastatic Prostate Cancer
- Advances in the Treatment of Metastatic Prostate Cancer
- Updates on the Treatment & Care of Bone Metastases
- The Role of Chemotherapy, Radiation Oncology & Targeted Treatments
- What is Radioligand Therapy?
- Radioligand Therapy for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- How Clinical Trials Contribute to Your Treatment Options
- The Role of Precision Medicine
- Tips to Manage Treatment Side Effects, Symptoms, Discomfort & Pain
- The Role of Physical Activity
- Guidelines to Prepare for Telehealth/Telemedicine Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Quality-of-Life Concerns & Follow-Up Appointments
- Questions for Our Panel of Experts
Speakers
Facilitator
Facilitator
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Certified Health Education Specialists (CHES®): This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hour. Cancer Care, Inc is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
To request continuing education paperwork, please email your name, profession, and address to [email protected] after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.